Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA

Journal of Controlled Release : Official Journal of the Controlled Release Society
Swati KoppuChristine Dufes

Abstract

The possibility of using genes as medicines to treat cancer is limited by the lack of safe and efficacious delivery systems able to deliver therapeutic genes selectively to tumors by intravenous administration. We investigate if the conjugation of the polypropylenimine dendrimer to transferrin, whose receptors are overexpressed on numerous cancers, could result in a selective gene delivery to tumors after intravenous administration, leading to an increased therapeutic efficacy. The objectives of this study are to evaluate the targeting and therapeutic efficacies of a novel transferrin-bearing polypropylenimine dendrimer. The intravenous administration of transferrin-bearing polypropylenimine polyplex resulted in gene expression mainly in the tumors. Consequently, the intravenous administration of the delivery system complexed to a therapeutic DNA led to a rapid and sustained tumor regression over one month, with long-term survival of 100% of the animals (90% complete response, 10% partial response).The treatment was well tolerated by the animals, with no apparent signs of toxicity. Transferrin-bearing polypropylenimine may thus be a promising gene delivery system for cancer therapy.

Citations

Jan 10, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Baowei SuManfred Ogris
Mar 15, 2011·Immunotherapy·Francois Fay, Christopher J Scott
Feb 28, 2013·Therapeutic Delivery·Neelesh Kumar MehraNarendra K Jain
Nov 1, 2010·Therapeutic Delivery·Himanshu BhattacharjeeGeorge C Wood
Apr 9, 2014·Biomaterials·Hongmei LiuYiyun Cheng
Nov 22, 2014·Nanomedicine·Sukrut Somani, Christine Dufès
Feb 16, 2012·Journal of Drug Targeting·Daiki OmataYukihiko Aramaki
Aug 24, 2013·Journal of Drug Targeting·Jing YaoLeaf Huang
Apr 5, 2011·Journal of Drug Targeting·Ajay KumarSrinath Palakurthi
Jun 17, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sukrut SomaniChristine Dufès
Feb 26, 2015·Proceedings of the National Academy of Sciences of the United States of America·John A RonaldSanjiv S Gambhir
Jul 30, 2011·International Journal of Pharmaceutics·Tao WangVladimir P Torchilin
May 7, 2015·Chemical Reviews·Jiepin YangYiyun Cheng
Feb 22, 2011·Nanomedicine : Nanotechnology, Biology, and Medicine·Hibah AldawsariChristine Dufès
Mar 2, 2016·Journal of Biomaterials Science. Polymer Edition·Nitin DwivediPrashant Kesharwani
Dec 15, 2010·Biotechnology Advances·Martin E BrandsmaShengwu Ma
Feb 28, 2014·The Journal of Membrane Biology·Stephanie Tortorella, Tom C Karagiannis
Sep 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sukrut SomaniChristine Dufès
Apr 16, 2015·Chemical Reviews·Ulrich Lächelt, Ernst Wagner
Sep 11, 2014·Nanomedicine·Andrew OwenVicki Stone
Feb 7, 2015·Macromolecular Bioscience·Dongsheng He, Ernst Wagner
Jul 15, 2015·Applied Biochemistry and Biotechnology·Maryam HashemiMohammad Ramezani
May 3, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Li Ying LimChristine Dufès
Jun 23, 2015·Nanomedicine·Sukrut Somani, Christine Dufès
Aug 20, 2011·Biochimica Et Biophysica Acta·Tracy R DanielsManuel L Penichet
Sep 17, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Max KullbergThomas J Anchordoquy
May 21, 2016·Cancer Gene Therapy·K Mann, M Kullberg
Jun 2, 2016·Expert Opinion on Drug Delivery·Kristen L KozielskiJordan J Green
Aug 28, 2012·Journal of the American Chemical Society·Riki ToitaYoshiki Katayama
Jul 28, 2016·Future Oncology·Irina S Babina
Jan 18, 2018·Topics in Current Chemistry·Dongsheng HeJiasheng Tu
Jun 14, 2015·Journal of Neuro-oncology·Nolan Ung, Isaac Yang
Feb 10, 2017·Topics in Current Chemistry·Peng Zhang, Ernst Wagner
Nov 20, 2020·International Journal of Biological Macromolecules·Mona M Agwa, Sally Sabra

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.